Health Catalyst, Inc. (NASDAQ:HCAT) Receives $2.77 Average PT from Analysts

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have earned a consensus recommendation of “Hold” from the thirteen ratings firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $2.8409.

A number of research firms have weighed in on HCAT. Wells Fargo & Company boosted their target price on shares of Health Catalyst from $1.00 to $1.75 and gave the company an “equal weight” rating in a research note on Friday. Stifel Nicolaus dropped their target price on shares of Health Catalyst from $3.75 to $2.00 and set a “hold” rating on the stock in a research note on Friday, March 13th. Canaccord Genuity Group dropped their target price on shares of Health Catalyst from $5.00 to $2.00 and set a “buy” rating on the stock in a research note on Friday, March 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Health Catalyst in a research note on Wednesday, June 24th. Finally, Stephens dropped their target price on shares of Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HCAT. First Light Asset Management LLC raised its position in shares of Health Catalyst by 9.9% in the third quarter. First Light Asset Management LLC now owns 13,436,220 shares of the company’s stock valued at $38,293,000 after purchasing an additional 1,206,039 shares during the period. HighMark Wealth Management LLC raised its position in shares of Health Catalyst by 139.0% in the fourth quarter. HighMark Wealth Management LLC now owns 741,482 shares of the company’s stock valued at $1,772,000 after purchasing an additional 431,200 shares during the period. Net Worth Advisory Group bought a new stake in shares of Health Catalyst in the fourth quarter valued at approximately $87,000. Strong Retirement Solutions LLC bought a new stake in shares of Health Catalyst in the fourth quarter valued at approximately $89,000. Finally, Dynamic Technology Lab Private Ltd raised its position in shares of Health Catalyst by 52.4% in the third quarter. Dynamic Technology Lab Private Ltd now owns 29,630 shares of the company’s stock valued at $84,000 after purchasing an additional 10,183 shares during the period. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Health Catalyst Stock Up 3.2%

Health Catalyst stock opened at $1.96 on Tuesday. Health Catalyst has a fifty-two week low of $0.96 and a fifty-two week high of $4.13. The stock has a market cap of $144.82 million, a PE ratio of -0.53 and a beta of 1.66. The firm’s 50-day simple moving average is $1.50 and its 200 day simple moving average is $1.75. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.69 and a current ratio of 1.69.

Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings results on Monday, May 11th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.01. Health Catalyst had a negative net margin of 87.69% and a negative return on equity of 3.52%. The business had revenue of $70.76 million for the quarter, compared to analysts’ expectations of $69.24 million. Research analysts predict that Health Catalyst will post -0.25 EPS for the current fiscal year.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.